| 标题 |
SKYGLO: A Global Phase III Randomized Study Evaluating Glofitamab Plus Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients with Large B-Cell Lymphoma (LBCL) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Ranjana H. Advani; Michael J. Dickinson; Christopher P. Fox; Brad Kahl; Alex F. Herrera; et al 出版日期:2024-12-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)